Successful ibrutinib treatment for central nervous system relapse of chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation

[1] Michallet M(2020)Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia Bone Marrow Transplant 55 884-890

[2] Dreger P(2021)Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation Hematol Oncol 39 267-269

[3] Sobh M(2017)Ibrutinib monotherapy as effective treatment of central nervous system involvement by chronic lymphocytic leukaemia Br J Haematol 176 829-831

[4] Innocenti I(2004)Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia Cancer 101 2788-2801

[5] Sora F(1998)A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111 Blood 92 1556-1564

[6] Autore F(2016)Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia Blood 127 2356-2358

[7] Chiusolo P(2020)Refractory chronic lymphocytic leukemia with central nervous system involvement: a case report with literature review J Blood Med 11 487-502

[8] Giammarco S(2018)Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature Ann Hematol 97 1627-1632

[9] Metafuni E(2016)Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT Blood 128 2899-2908

[10] Bacigalupo A(undefined)undefined undefined undefined undefined-undefined

[1] Michallet M(2020)Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia Bone Marrow Transplant 55 884-890

[2] Dreger P(2021)Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation Hematol Oncol 39 267-269

[3] Sobh M(2017)Ibrutinib monotherapy as effective treatment of central nervous system involvement by chronic lymphocytic leukaemia Br J Haematol 176 829-831

[4] Innocenti I(2004)Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia Cancer 101 2788-2801

[5] Sora F(1998)A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111 Blood 92 1556-1564

[6] Autore F(2016)Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia Blood 127 2356-2358

[7] Chiusolo P(2020)Refractory chronic lymphocytic leukemia with central nervous system involvement: a case report with literature review J Blood Med 11 487-502

[8] Giammarco S(2018)Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature Ann Hematol 97 1627-1632

[9] Metafuni E(2016)Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT Blood 128 2899-2908

[10] Bacigalupo A(undefined)undefined undefined undefined undefined-undefined